NVNO
Price:
$3.4
Market Cap:
$59.62M
enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.[Read more]
Industry
Medical - Devices
IPO Date
2018-05-31
Stock Exchange
NASDAQ
Ticker
NVNO
According to enVVeno Medical Corporation’s latest financial reports and current stock price. The company's current ROE is -48.73%. This represents a change of 299.22% compared to the average of -12.21% of the last 4 quarters.
The mean historical ROE of enVVeno Medical Corporation over the last ten years is -143.41%. The current -48.73% ROE has changed -66.02% with respect to the historical average. Over the past ten years (40 quarters), NVNO's ROE was at its highest in in the March 2020 quarter at 7.93%. The ROE was at its lowest in in the June 2020 quarter at -440.38%.
Average
-143.41%
Median
-40.34%
Minimum
-770.29%
Maximum
80.28%
Discovering the peaks and valleys of enVVeno Medical Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 110.79%
Maximum Annual ROE = 80.28%
Minimum Annual Increase = -1014.93%
Minimum Annual ROE = -770.29%
Year | ROE | Change |
---|---|---|
2023 | -50.90% | -18.89% |
2022 | -62.75% | 110.79% |
2021 | -29.77% | -76.31% |
2020 | -125.67% | -83.69% |
2019 | -770.29% | 20.27% |
2018 | -640.47% | -1014.93% |
2017 | 70.00% | -12.81% |
2016 | 80.28% | 79.03% |
2015 | 44.84% | -11.41% |
The current ROE of enVVeno Medical Corporation (NVNO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-47.81%
5-year avg
-207.88%
10-year avg
-143.41%
enVVeno Medical Corporation’s ROE is less than Aziyo Biologics, Inc. (196.38%), greater than Ainos, Inc. (-64.53%), greater than Surmodics, Inc. (-1.16%), greater than LENSAR, Inc. (-30.16%), greater than IRIDEX Corporation (-134.37%), greater than RxSight, Inc. (-19.33%), greater than AxoGen, Inc. (-17.30%), greater than Treace Medical Concepts, Inc. (-49.53%), greater than Pulmonx Corporation (-53.88%), greater than Orthofix Medical Inc. (-20.68%), greater than PetVivo Holdings, Inc. (-1189.54%), greater than Talis Biomedical Corporation (-79.73%), greater than Tenon Medical, Inc. (-715.68%), greater than STRATA Skin Sciences, Inc. (-69.56%), less than Sientra, Inc. (414.58%), less than ProSomnus, Inc. Common Stock (50.75%), less than LivaNova PLC (1.87%), less than Electromed, Inc. (12.44%), greater than OrthoPediatrics Corp. (-6.73%),
Company | ROE | Market cap |
---|---|---|
196.38% | $24.21M | |
-64.53% | $3.50M | |
-1.16% | $536.01M | |
-30.16% | $69.88M | |
-134.37% | $24.46M | |
-19.33% | $2.06B | |
-17.30% | $635.53M | |
-49.53% | $326.50M | |
-53.88% | $281.70M | |
-20.68% | $668.06M | |
-1189.54% | $11.20M | |
-79.73% | $3.14M | |
-715.68% | $1.82M | |
-69.56% | $12.30M | |
414.58% | $2.08M | |
50.75% | $8.18M | |
1.87% | $2.66B | |
12.44% | $191.80M | |
-6.73% | $677.52M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like enVVeno Medical Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like enVVeno Medical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is enVVeno Medical Corporation's ROE?
How is the ROE calculated for enVVeno Medical Corporation (NVNO)?
What is the highest ROE for enVVeno Medical Corporation (NVNO)?
What is the 3-year average ROE for enVVeno Medical Corporation (NVNO)?
What is the 5-year average ROE for enVVeno Medical Corporation (NVNO)?
How does the current ROE for enVVeno Medical Corporation (NVNO) compare to its historical average?